EP Patent

EP2730291A1 — Internal Tamponade Composition

Assigned to Fluoron GmbH · Expires 2014-05-14 · 12y expired

What this patent protects

The present invention relates to a composition for use in the treatment of retinal detachment. In particular, the composition comprises a mixture of at least two oils and one or more semifluorinated alkanes for use as temporary tamponades in the treatment of retinal detachment.

USPTO Abstract

The present invention relates to a composition for use in the treatment of retinal detachment. In particular, the composition comprises a mixture of at least two oils and one or more semifluorinated alkanes for use as temporary tamponades in the treatment of retinal detachment.

Drugs covered by this patent

Patent Metadata

Patent number
EP2730291A1
Jurisdiction
EP
Classification
—
Expires
2014-05-14
Drug substance claim
No
Drug product claim
No
Assignee
Fluoron GmbH
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.